Touch-down reverse transcriptase-PCR detection of IgV(H) rearrangement and Sybr-Green-based real-time RT-PCR quantitation of minimal residual disease in patients with chronic lymphocytic leukemia.

Sona Peková, Jana Marková, Petr Pajer, Michal Dvorák, Petr Cetkovský, Jirí Schwarz
{"title":"Touch-down reverse transcriptase-PCR detection of IgV(H) rearrangement and Sybr-Green-based real-time RT-PCR quantitation of minimal residual disease in patients with chronic lymphocytic leukemia.","authors":"Sona Peková,&nbsp;Jana Marková,&nbsp;Petr Pajer,&nbsp;Michal Dvorák,&nbsp;Petr Cetkovský,&nbsp;Jirí Schwarz","doi":"10.2165/00066982-200509010-00004","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with chronic lymphocytic leukemia (CLL) can relapse even after aggressive therapy and autografts. It is commonly assumed that to prevent relapse the level of minimal residual disease (MRD) should be as low as possible. To evaluate MRD, highly sensitive quantitative assays are needed.</p><p><strong>Aim: </strong>The aim of the study was to develop a robust and sensitive method for detection of the clonal immunoglobulin heavy-chain variable (IgV(H)) rearrangement in CLL and to introduce a highly sensitive and specific methodology for MRD monitoring in patients with CLL who undergo intensive treatment.</p><p><strong>Methods: </strong>As a prerequisite for MRD detection, touch-down reverse transcriptase (RT)-PCR using degenerate primers were used for the diagnostic identification of (H) gene rearrangement(s). For quantitative MRD detection in 18 patients, we employed a real-time RT-PCR assay (RQ-PCR) making use of patient-specific primers and the cost-saving Sybr-Green reporter dye (SG). For precise calibration of RQ-PCR, patient-specific IgV(H) sequences were cloned.</p><p><strong>Results: </strong>Touch-down RT-PCR with degenerate primers allowed the successful detection of IgV(H) clonal rearrangement(s) in 252 of 257 (98.1%) diagnostic samples. Biallelic rearrangements were found in 27 of 252 (10.7%) cases. Degenerate primers used for the identification of clonal expansion at diagnosis were not sensitive enough for MRD detection. In contrast, our RQ-PCR assay using patient-specific primers and SG reached the sensitivity of 10(-)(6). We demonstrated MRD in each patient tested, including four of four patients in complete remission following autologous hematopoietic stem cell transplantation (HSCT) and three of three following allogeneic 'mini'-HSCT. Increments in MRD might herald relapse; aggressive chemotherapy could induce molecular remission.</p><p><strong>Conclusions: </strong>Our touch-down RT-PCR has higher efficiency to detect clonal IgV(H) rearrangements including the biallelic ones. MRD quantitation of IgV(H) expression using SG-based RQ-PCR represents a highly specific, sensitive, and economic alternative to the current quantitative methods.</p>","PeriodicalId":79690,"journal":{"name":"Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology","volume":"9 1","pages":"23-34"},"PeriodicalIF":0.0000,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2165/00066982-200509010-00004","citationCount":"10","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2165/00066982-200509010-00004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 10

Abstract

Background: Patients with chronic lymphocytic leukemia (CLL) can relapse even after aggressive therapy and autografts. It is commonly assumed that to prevent relapse the level of minimal residual disease (MRD) should be as low as possible. To evaluate MRD, highly sensitive quantitative assays are needed.

Aim: The aim of the study was to develop a robust and sensitive method for detection of the clonal immunoglobulin heavy-chain variable (IgV(H)) rearrangement in CLL and to introduce a highly sensitive and specific methodology for MRD monitoring in patients with CLL who undergo intensive treatment.

Methods: As a prerequisite for MRD detection, touch-down reverse transcriptase (RT)-PCR using degenerate primers were used for the diagnostic identification of (H) gene rearrangement(s). For quantitative MRD detection in 18 patients, we employed a real-time RT-PCR assay (RQ-PCR) making use of patient-specific primers and the cost-saving Sybr-Green reporter dye (SG). For precise calibration of RQ-PCR, patient-specific IgV(H) sequences were cloned.

Results: Touch-down RT-PCR with degenerate primers allowed the successful detection of IgV(H) clonal rearrangement(s) in 252 of 257 (98.1%) diagnostic samples. Biallelic rearrangements were found in 27 of 252 (10.7%) cases. Degenerate primers used for the identification of clonal expansion at diagnosis were not sensitive enough for MRD detection. In contrast, our RQ-PCR assay using patient-specific primers and SG reached the sensitivity of 10(-)(6). We demonstrated MRD in each patient tested, including four of four patients in complete remission following autologous hematopoietic stem cell transplantation (HSCT) and three of three following allogeneic 'mini'-HSCT. Increments in MRD might herald relapse; aggressive chemotherapy could induce molecular remission.

Conclusions: Our touch-down RT-PCR has higher efficiency to detect clonal IgV(H) rearrangements including the biallelic ones. MRD quantitation of IgV(H) expression using SG-based RQ-PCR represents a highly specific, sensitive, and economic alternative to the current quantitative methods.

慢性淋巴细胞白血病患者IgV(H)重排的触地逆转录酶- pcr检测及基于sybr - green的微小残留病实时RT-PCR定量
背景:慢性淋巴细胞白血病(CLL)患者即使在积极治疗和自体移植后也可能复发。通常认为,为了防止复发,最小残留病(MRD)的水平应尽可能低。为了评估MRD,需要高灵敏度的定量分析。目的:该研究的目的是开发一种强大而敏感的方法来检测CLL中克隆免疫球蛋白重链变量(IgV(H))重排,并引入一种高度敏感和特异性的方法来监测接受强化治疗的CLL患者的MRD。方法:作为MRD检测的前提条件,采用简并引物触地逆转录酶(RT)-PCR对(H)基因重排进行诊断鉴定。为了对18例患者进行定量MRD检测,我们采用了实时RT-PCR法(RQ-PCR),利用患者特异性引物和节省成本的Sybr-Green报告染料(SG)。为了精确校准RQ-PCR,我们克隆了患者特异性IgV(H)序列。结果:采用退化引物的触地RT-PCR, 257份诊断样本中有252份(98.1%)成功检测到IgV(H)克隆重排。252例中有27例(10.7%)发现双等位基因重排。诊断时用于克隆扩增鉴定的简并引物对MRD检测不够敏感。相比之下,我们使用患者特异性引物和SG的RQ-PCR检测达到了10(-)的灵敏度(6)。我们在每个被测试的患者中证实了MRD,包括4例自体造血干细胞移植(HSCT)后完全缓解的患者中的4例和3例异体“mini”-HSCT后完全缓解的患者中的3例。MRD的增加可能预示着复发;积极化疗可诱导分子缓解。结论:我们的触地RT-PCR检测IgV(H)克隆重排的效率较高,包括双等位基因重排。使用基于sgg的RQ-PCR对IgV(H)表达进行MRD定量,是目前定量方法的一种高度特异性、敏感性和经济性的替代方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信